SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of
Investors of The Clorox Company - CLX
NEW YORK, June 4, 2014
NEW YORK, June 4, 2014 /PRNewswire/ -- Pomerantz LLP is investigating claims
on behalf of investors of The Clorox Company ("Clorox" or the "Company")
(NYSE: CLX). Investors are advised to contact Robert S. Willoughby at
email@example.com or 888-476-6529, ext. 237.
The investigation concerns whether Clorox and certain of its officers and/or
directors have violated Sections 10(b) and 20(a) of the Securities Exchange
Act of 1934.
On Friday, May 30, 2014, a report in The New York Times stated that, "Federal
authorities are examining a series of well-timed trades made by golfer Phil
Mickelson and Las Vegas gambler William T. Walters," on potentially nonpublic
information provided by investor Carl Icahn, in the days leading up to Icahn's
July 15, 2011 tender offer announcement for Clorox.
On the news of Icahn's $76.50 per share offer announcement, Clorox options and
shares soared in value, which closed at $74.55 per share, up 8.9%, on July 15,
The Pomerantz Firm, with offices in New York, Chicago, San Diego and Florida,
is acknowledged as one of the premier firms in the areas of corporate,
securities, and antitrust class litigation. Founded by the late Abraham L.
Pomerantz, known as the dean of the class action bar, the Pomerantz Firm
pioneered the field of securities class actions. Today, more than 70 years
later, the Pomerantz Firm continues in the tradition he established, fighting
for the rights of the victims of securities fraud, breaches of fiduciary duty,
and corporate misconduct. The Firm has recovered numerous multimillion-dollar
damages awards on behalf of class members. See www.pomerantzlaw.com.
Robert S. Willoughby
SOURCE Pomerantz LLP
Press spacebar to pause and continue. Press esc to stop.